Skip to main content
Signal8

Kaul Inderjit

SEC insider (Form 3/4/5 filer). CIK 0002095703. Director at Minerva Neurosciences, Inc. (NERV). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in BURLINGTON, MA.

Companies Kaul Inderjit has filed insider reports for

  • Minerva Neurosciences, Inc. (NERV): Director
Kaul Inderjit profile photo

Kaul Inderjit

CIK: 0002095703

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Minerva Neurosciences, Inc. logo
NERV

Minerva Neurosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Minerva Neurosciences, Inc. logo
    NERV

    Minerva Neurosciences, Inc.

    Aug 3, 2026
    Award

    Stock Option (right to buy)

    Direct
    12.1K shares-
  • Minerva Neurosciences, Inc. logo
    NERV

    Minerva Neurosciences, Inc.

    Jun 3, 2026
    Award

    Stock Option (right to buy)

    Direct
    50K shares-
  • Minerva Neurosciences, Inc. logo
    NERV

    Minerva Neurosciences, Inc.

    Mar 31, 2026
    Award

    Stock Option (right to buy)

    Direct
    12.2K shares-
  • Minerva Neurosciences, Inc. logo
    NERV

    Minerva Neurosciences, Inc.

    Dec 22, 2025
    Award

    Stock Option (right to buy)

    Direct
    364.5K shares-
  • Minerva Neurosciences, Inc. logo
    NERV

    Minerva Neurosciences, Inc.

    Nov 14, 2025
    Award

    Stock Option (right to buy)

    Direct
    9.5K shares-

1-5 of 5